Mariner
VRCA icon

Mariner’s Verrica Pharmaceuticals VRCA Stock Holding History

Mariner’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Buy
207,230
+182,686
+744% +$1.14M ﹤0.01% 1776
2026
Q1 		$130K Hold
24,544
– – ﹤0.01% 3275
2025
Q4 		$204K Sell
24,544
-6
-0% -$33 ﹤0.01% 3155
2025
Q3 		$106K Sell
24,550
-1,980
-7% -$11.9K ﹤0.01% 3344
2025
Q2 		$141K Buy
26,530
+10,011
+61% +$53.9K ﹤0.01% 3164
2025
Q1 		$73K Buy
16,519
+7,541
+84% +$48.8K ﹤0.01% 3247
2024
Q4 		$62.8K Sell
8,978
-16
-0.2% -$176 ﹤0.01% 3262
2024
Q3 		$130K Buy
8,994
+7,245
+414% +$326K ﹤0.01% 3041
2024
Q2 		$127K Hold
1,749
– – ﹤0.01% 2901
2024
Q1 		$104K Buy
+1,749
New +$96.6K ﹤0.01% 2924

Other funds holding VRCA

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $149M AUM 39.81% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Mariner's VRCA Position: Q2 2026 in Review

Mariner increased its Verrica Pharmaceuticals (VRCA) stake by 744% in Q2 2026, buying an estimated $1.14M and bringing the position to 207,230 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1776.

Mariner first reported a position in VRCA in Q1 2024 and has held it in 10 quarters since. 43 funds tracked by Wall St. Rank hold VRCA as of Q2 2026.

  • Mariner held 207,230 shares of Verrica Pharmaceuticals worth $1.27M as of Q2 2026.
  • Mariner bought 182,686 Verrica Pharmaceuticals shares in Q2 2026, an estimated $1.14M.
  • Verrica Pharmaceuticals made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #1776 holding.
  • Mariner first reported a position in Verrica Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • 43 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.